Kalkine Media ties the attention on Lilly to orforglipron's progress, arguing a pill could scale cheaper than injectables and ease supply limits.
Recap by typeshit. Full story at Kalkine Media.
Smaller portions could become more common on shelves, with inflation and GLP-1 appetite changes both pushing food makers toward personal packs.
Chokshi notes the sales were 0.4% of Lilly's $23 billion quarter, and that Divi's Labs hasn't announced any role in making the drug.
Oral Wegovy brought in about $850 million in H1 2026 and holds over 80% of new US oral scripts. Lilly says Foundayo volume doubled in a month.
Gottlieb also covers the FDA's new Rare Disease Framework Initiative and the latest on the measles outbreak in the CNBC interview.
Dr Bajekal flags that people on Mounjaro, semaglutide or Wegovy should talk it through with their doctor ahead of an operation.
Officers say the seized pharmaceuticals were worth $280,106.20 in total, part of a wider push against smuggled weight loss and peptide products.
Loading…